AMPH vs TECH
Amphastar P (AMPH) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AMPH and TECH stock pages for the full models.
Not investment advice.